Research InnovationPublications Fenfluramine: New Treatment for Seizures in Dravet Syndrome
Fenfluramine: New Treatment for Seizures in Dravet Syndrome
Pierce, J. G.; Mithal, D. S.
Pediatr Neurol Briefs. 2020 Mar 20; 34:8
Abstract
Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled in the study.